Physician
Desert Valley Medical Group, INC.
Desert Valley Medical Group, INC. was paid $15.92M by Medicaid between Jan 2018 and Dec 2024, across 188 billing codes. Its largest line is 99284, emergency room visit (serious) — 15% of everything it billed.
33Billing provider infoDESERT VALLEY MEDICAL GROUP, INC.
VICTORVILLE, CA 92395
VICTORVILLE, CA 92395
33aNPI1801848452assigned 05/16/2006
33bProvider typeAnesthesiology Physician
28Total paid$15.92M
24GClaims644,735
24DCodes billed188
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Anesthesiology Physician providers in California
Rank by total paid#5 of 415
Median peer was paid$17K
This provider vs. median911×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 55,132 | $2.44M | |
| 2019 | 57,811 | $2.19M | |
| 2020 | 45,732 | $1.85M | |
| 2021 | 61,670 | $2.15M | |
| 2022 | 102,937 | $2.38M | |
| 2023 | 153,025 | $2.28M | |
| 2024incomplete | 168,428 | $2.63M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 15% | 41,223 | 40,528 | $2.44M |
| 99223 | Prolong inpt eval add15 m | 12% | 13,907 | 13,372 | $1.98M |
| S9083 | Global fee urgent care centers | 8.5% | 27,670 | 26,058 | $1.36M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 8.5% | 16,811 | 16,448 | $1.35M |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 7.7% | 31,317 | 16,087 | $1.22M |
| 59425 | 6.7% | 17,018 | 9,455 | $1.06M | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 4.7% | 8,556 | 4,673 | $751K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 4.1% | 16,620 | 16,455 | $660K |
| 99239 | Hospital discharge day management, more than 30 minutes | 3.5% | 10,424 | 10,140 | $554K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3.0% | 31,202 | 29,423 | $484K |
| 59409 | Vaginal delivery only (with or without episiotomy and/or forceps) | 2.9% | 832 | 819 | $454K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 2.4% | 15,044 | 7,098 | $385K |
176 more codes
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 2.2% | 31,080 | $346K |
| 99222 | Initial hospital care, per day, moderate complexity | 2.2% | 3,419 | $344K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.2% | 9,046 | $194K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.2% | 4,305 | $188K |
| 99213 | Doctor's office visit, returning patient (routine) | 1.2% | 13,977 | $184K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 1,679 | $156K |
| 99255 | <1% | 1,801 | $143K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 2,811 | $139K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 4,855 | $133K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 710 | $113K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 3,029 | $110K |
| 59025 | Fetal non-stress test | <1% | 11,437 | $104K |
| 99460 | <1% | 1,906 | $94K | |
| 99254 | <1% | 1,565 | $91K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 1,210 | $89K |
| Z1034 | <1% | 1,609 | $88K | |
| 59430 | <1% | 1,351 | $74K | |
| 99381 | <1% | 1,272 | $65K | |
| 99497 | <1% | 1,104 | $45K | |
| 99205 | Prolong outpt/office vis | <1% | 452 | $38K |
| 92551 | <1% | 3,522 | $37K | |
| 73630 | <1% | 2,427 | $37K | |
| 59514 | <1% | 71 | $32K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 3,303 | $24K |
| 99462 | <1% | 833 | $22K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,977 | $21K |
| 93458 | <1% | 108 | $21K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 4,416 | $19K |
| 0011A | <1% | 485 | $19K | |
| 0012A | <1% | 436 | $17K | |
| 11721 | <1% | 537 | $14K | |
| 90671 | <1% | 1,727 | $14K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 227 | $14K |
| 93000 | <1% | 745 | $14K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 4,593 | $14K |
| 47562 | <1% | 28 | $12K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 568 | $7K |
| 36556 | <1% | 139 | $7K | |
| 73610 | <1% | 525 | $7K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 1,125 | $6K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 2,048 | $5K |
| 93016 | <1% | 283 | $5K | |
| 88720 | <1% | 1,211 | $5K | |
| 99310 | Prolong nursin fac eval 15m | <1% | 464 | $5K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 434 | $5K |
| 90647 | <1% | 1,605 | $5K | |
| 90723 | <1% | 1,125 | $5K | |
| 81002 | <1% | 6,324 | $5K | |
| 99383 | <1% | 535 | $4K | |
| 97803 | <1% | 114 | $4K | |
| 99152 | <1% | 105 | $4K | |
| 93018 | <1% | 287 | $4K | |
| 93227 | <1% | 240 | $4K | |
| 90681 | <1% | 955 | $3K | |
| Z1032 | <1% | 24 | $3K | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 261 | $3K |
| 90670 | <1% | 321 | $3K | |
| 0002A | <1% | 61 | $2K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 44 | $2K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 165 | $2K |
| 0031A | <1% | 54 | $2K | |
| 20550 | <1% | 36 | $2K | |
| G9920 | Screening performed and negative | <1% | 2,209 | $2K |
| 73130 | <1% | 201 | $2K | |
| 0001A | <1% | 48 | $2K | |
| 99252 | <1% | 55 | $2K | |
| 99253 | <1% | 34 | $2K | |
| 99382 | <1% | 154 | $2K | |
| 99292 | <1% | 41 | $2K | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | <1% | 828 | $2K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,358 | $1K |
| 11056 | <1% | 53 | $1K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 17 | $1K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 13 | $1K |
| 99406 | <1% | 124 | $1K | |
| 96156 | <1% | 14 | $1K | |
| 73110 | <1% | 88 | $926.71 | |
| 0013A | <1% | 21 | $840.00 | |
| 12002 | <1% | 12 | $836.64 | |
| 90686 | <1% | 494 | $832.94 | |
| 93308 | <1% | 37 | $727.76 | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 1,187 | $720.22 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 213 | $710.75 |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 26 | $707.72 |
| Z6204 | <1% | 79 | $664.66 | |
| 73564 | <1% | 47 | $653.38 | |
| 81025 | <1% | 406 | $617.19 | |
| 31500 | <1% | 12 | $608.05 | |
| 0003A | <1% | 15 | $590.00 | |
| 99153 | Mod sedat endo service >5yrs | <1% | 26 | $553.36 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,818 | $535.64 |
| 94010 | <1% | 82 | $514.87 | |
| 99306 | Prolong nursin fac eval 15m | <1% | 45 | $499.66 |
| 99188 | <1% | 1,789 | $499.50 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,246 | $491.90 |
| 99384 | <1% | 94 | $491.60 | |
| 85610 | <1% | 124 | $406.33 | |
| 90656 | <1% | 167 | $389.66 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 1,252 | $375.47 |
| 3074F | <1% | 26,886 | $350.01 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 869 | $331.57 |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 488 | $323.31 |
| 99407 | <1% | 18 | $306.19 | |
| 73030 | <1% | 28 | $288.18 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 234 | $266.28 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 387 | $257.47 |
| 99441 | <1% | 139 | $249.15 | |
| 99496 | <1% | 27 | $223.48 | |
| 73562 | <1% | 43 | $214.00 | |
| 90685 | <1% | 66 | $208.25 | |
| 90633 | <1% | 788 | $187.65 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 331 | $186.32 |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 39 | $160.85 |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 499 | $129.90 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 101 | $129.90 |
| 90734 | <1% | 300 | $116.64 | |
| 90716 | <1% | 389 | $116.10 | |
| 90696 | <1% | 216 | $107.91 | |
| 90710 | <1% | 239 | $98.91 | |
| 90707 | <1% | 361 | $98.28 | |
| 87807 | <1% | 240 | $92.92 | |
| 90648 | <1% | 34 | $89.91 | |
| 90700 | <1% | 314 | $89.55 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 45 | $70.77 |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 398 | $66.06 |
| 90620 | <1% | 103 | $62.91 | |
| 94760 | <1% | 806 | $60.33 | |
| 96127 | <1% | 244 | $54.85 | |
| 99070 | <1% | 96 | $53.28 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 24 | $49.40 |
| 90651 | <1% | 235 | $44.82 | |
| 85018 | <1% | 521 | $39.77 | |
| 82962 | <1% | 92 | $32.49 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 14 | $29.80 |
| 90715 | <1% | 95 | $26.91 | |
| 99307 | <1% | 14 | $24.66 | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 504 | $20.20 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 37 | $14.31 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 92 | $13.26 |
| 99053 | <1% | 42 | $7.35 | |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | <1% | 12 | $4.24 |
| 99173 | <1% | 206 | $2.30 | |
| 87625 | <1% | 151 | $1.51 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 29 | $1.19 |
| 83655 | <1% | 191 | $0.04 | |
| 1111F | <1% | 52,664 | $0.04 | |
| 1159F | <1% | 52,984 | $0.03 | |
| 1160F | <1% | 53,123 | $0.03 | |
| 3078F | <1% | 29,692 | $0.02 | |
| 3077F | <1% | 7,009 | $0.01 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 0% | 3,732 | $0.00 |
| 90461 | 0% | 1,074 | $0.00 | |
| 1090F | 0% | 379 | $0.00 | |
| 1158F | 0% | 66 | $0.00 | |
| 3725F | 0% | 803 | $0.00 | |
| 4040F | 0% | 28 | $0.00 | |
| 3288F | 0% | 24 | $0.00 | |
| 0502F | 0% | 53 | $0.00 | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 0% | 12 | $0.00 |
| 1175F | 0% | 25 | $0.00 | |
| 3075F | 0% | 5,211 | $0.00 | |
| 3079F | 0% | 8,976 | $0.00 | |
| 1126F | 0% | 341 | $0.00 | |
| 1125F | 0% | 138 | $0.00 | |
| 3080F | 0% | 1,657 | $0.00 | |
| 0500F | 0% | 56 | $0.00 | |
| 99024 | 0% | 70 | $0.00 | |
| 3017F | 0% | 35 | $0.00 | |
| 3351F | 0% | 236 | $0.00 | |
| 0501F | 0% | 32 | $0.00 | |
| 1220F | 0% | 63 | $0.00 | |
| 3353F | 0% | 28 | $0.00 | |
| 1170F | 0% | 39 | $0.00 | |
| 1101F | 0% | 13 | $0.00 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 0% | 13 | $0.00 |
| 3014F | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBHATIA, KAVITHA (OWNER)
| Provider | Location | Paid |
|---|---|---|
| Desert Valley Medical Group, INC. | Apple Valley, CA | $755K |
| Desert Valley Medical Group, INC. | Adelanto, CA | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.